| UHC Commercial Medical & Drug | Otoacoustic Emissions Testing (For Oxford Only) - Oxford Medical Policy | 2026-01-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Hyaluronate Derivatives (Viscosupplementation) | 2026-01-01 |
| Ambetter Health Texas Superior Medicaid Clinical | D. Centene clinical policy | 2026-01-01 |
| BCBS Iowa Medical Policies | Cosmetic and Reconstructive Services | 2026-01-01 |
| BCBS Iowa Medical Policies | Gender Affirming Services | 2026-01-01 |
| BCBS Iowa Medical Policies | Injection Therapy for Headache Management | 2026-01-01 |
| BCBS Iowa Medical Policies | Leqembi | 2026-01-01 |
| BCBS Iowa Medical Policies | Lutathera (Lutetium Lu 177 Dotatate)* | 2026-01-01 |
| BCBS Iowa Medical Policies | Miscellaneous Treatments for Varicose Veins/Venous Insufficiency | 2026-01-01 |
| BCBS Iowa Medical Policies | Remote Electrical Neuromodulation for Migraines | 2026-01-01 |